Tuesday, February 5, 2013

• Allergan Reports Mixed Q4, But Bullish Margin Outlookat Investor's Business Daily (Tue, Feb 5)
• ROCHE HOLDING LTD /FI FinancialsEDGAR Online Financials (Tue, Feb 5)

Friday, February 1, 2013

• Roche Grows in 2012Zacks (Fri, Feb 1)
• Merck Beats, Issues OutlookZacks (Fri, Feb 1)
• [video] Roche's CEO on Profit Pipelineat CNBC (Fri, Feb 1)

Thursday, January 31, 2013

• Pipeline Progress at EndocyteZacks (Thu, Jan 31)
• Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)Business Wire (Thu, Jan 31)

Wednesday, January 30, 2013

• Why Analysts Are Dead Wrong On Immunogenat Seeking Alpha (Wed, Jan 30)
• Roche Teams Up With AfraxisZacks (Wed, Jan 30)
• Cancer drugs give Roche a 2012 profit boostAP (Wed, Jan 30)
• Roche posts modest profit gain for 2012AP (Wed, Jan 30)

Monday, January 28, 2013

• Wider Loss at ImmunoGenZacks (Mon, Jan 28)

Friday, January 25, 2013

• Biogen, Illumina Ready Q4 Reports As Stocks Struggleat Investor's Business Daily (Fri, Jan 25)
• The Zacks Analyst Blog Highlights: Roche, Aetna, WellCare Health Plans, Coventry Health Care and HumanaZacks (Fri, Jan 25)

Thursday, January 24, 2013

• Label Expansion for Roche's AvastinZacks (Thu, Jan 24)

Wednesday, January 23, 2013

• FDA Approves New Use of Avastin Plus Chemotherapy for People with Metastatic Colorectal CancerBusiness Wire (Wed, Jan 23)

Friday, January 18, 2013

• Pipeline Advances at ExelixisZacks (Fri, Jan 18)
• Life Technologies Stock Hits High On Buyout Rumorsat Investor's Business Daily (Fri, Jan 18)
• [video] Fighting the Flu-demicat CNBC (Fri, Jan 18)

Thursday, January 17, 2013

• Shifts in Roche's Top BrassZacks (Thu, Jan 17)
• Astellas' sNDA for Tarceva AcceptedZacks (Thu, Jan 17)

Monday, January 14, 2013

• Setback for ArQule, Shares FallZacks (Mon, Jan 14)
• CDC estimates flu epidemic to cost U.S. businesses over $10B, FT saystheflyonthewall.com (Mon, Jan 14)

Thursday, January 10, 2013

• Pharmas Hope to Grow Fat With Obesity Drugsat Motley Fool (Thu, Jan 10)

Tuesday, January 8, 2013

• Regeneron Shares Fall After Sales Of Eye Drug Postedat Investor's Business Daily (Tue, Jan 8)

Add RHHBY News to My Yahoo!